Comparative Metabolic Flux Profiling of Melanoma Cell Lines

Metabolic rewiring is an established hallmark of cancer, but the details of this rewiring at a systems level are not well characterized. Here we acquire this insight in a melanoma cell line panel by tracking metabolic flux using isotopically labeled nutrients. Metabolic profiling and flux balance analysis were used to compare normal melanocytes to melanoma cell lines in both normoxic and hypoxic conditions. All melanoma cells exhibited the Warburg phenomenon; they used more glucose and produced more lactate than melanocytes. Other changes were observed in melanoma cells that are not described by the Warburg phenomenon. Hypoxic conditions increased fermentation of glucose to lactate in both melanocytes and melanoma cells (the Pasteur effect). However, metabolism was not strictly glycolytic, as the tricarboxylic acid (TCA) cycle was functional in all melanoma lines, even under hypoxia. Furthermore, glutamine was also a key nutrient providing a substantial anaplerotic contribution to the TCA cycle. In the WM35 melanoma line glutamine was metabolized in the “reverse” (reductive) direction in the TCA cycle, particularly under hypoxia. This reverse flux allowed the melanoma cells to synthesize fatty acids from glutamine while glucose was primarily converted to lactate. Altogether, this study, which is the first comprehensive comparative analysis of metabolism in melanoma cells, provides a foundation for targeting metabolism for therapeutic benefit in melanoma.

[1]  Chi V Dang,et al.  Rethinking the Warburg effect with Myc micromanaging glutamine metabolism. , 2010, Cancer research.

[2]  Chi V. Dang,et al.  Otto Warburg's contributions to current concepts of cancer metabolism , 2011, Nature Reviews Cancer.

[3]  A. H. Diwan,et al.  Human melanoma cells express functional receptors for thyroid-stimulating hormone. , 2006, Endocrine-related cancer.

[4]  S. Gambhir Molecular imaging of cancer with positron emission tomography , 2002, Nature Reviews Cancer.

[5]  R. Marais,et al.  Cellular senescence in naevi and immortalisation in melanoma: a role for p16? , 2006, British Journal of Cancer.

[6]  R. Deberardinis,et al.  Pyruvate carboxylase is required for glutamine-independent growth of tumor cells , 2011, Proceedings of the National Academy of Sciences.

[7]  T. Copetti,et al.  Anticancer Targets in the Glycolytic Metabolism of Tumors: A Comprehensive Review , 2011, Front. Pharmacol..

[8]  Y. Kluger,et al.  Phosphatidylinositol-3-Kinase as a Therapeutic Target in Melanoma , 2009, Clinical Cancer Research.

[9]  Omar Abdel-Wahab,et al.  The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. , 2010, Cancer cell.

[10]  D. L. Harris,et al.  Mechanistic stoichiometry of mitochondrial oxidative phosphorylation. , 1991, Biochemistry.

[11]  B. Bedogni,et al.  Hypoxia, melanocytes and melanoma – survival and tumor development in the permissive microenvironment of the skin , 2009, Pigment cell & melanoma research.

[12]  G. Semenza,et al.  HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. , 2006, Cell metabolism.

[13]  Adam L. Meadows,et al.  Metabolic and Morphological Differences between Rapidly Proliferating Cancerous and Normal Breast Epithelial Cells , 2008, Biotechnology progress.

[14]  G. Kalna,et al.  Metabolic Profiling of Hypoxic Cells Revealed a Catabolic Signature Required for Cell Survival , 2011, PloS one.

[15]  K. Flaherty,et al.  Identification of a novel subgroup of melanomas with KIT/cyclin-dependent kinase-4 overexpression. , 2008, Cancer research.

[16]  M. V. Heiden,et al.  Targeting cancer metabolism: a therapeutic window opens , 2011, Nature Reviews Drug Discovery.

[17]  N. Denko,et al.  HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. , 2006, Cell metabolism.

[18]  Gregory Stephanopoulos,et al.  Quantifying Reductive Carboxylation Flux of Glutamine to Lipid in a Brown Adipocyte Cell Line* , 2008, Journal of Biological Chemistry.

[19]  E. Gottlieb,et al.  Targeting metabolic transformation for cancer therapy , 2010, Nature Reviews Cancer.

[20]  Alok J. Saldanha,et al.  Java Treeview - extensible visualization of microarray data , 2004, Bioinform..

[21]  U. Sauer,et al.  Determination of metabolic flux ratios from 13C-experiments and gas chromatography-mass spectrometry data: protocol and principles. , 2007, Methods in molecular biology.

[22]  Massimo Libra,et al.  Melanoma: molecular pathogenesis and emerging target therapies (Review). , 2009, International journal of oncology.

[23]  Nathan E. Lewis,et al.  Deletion of Genes Encoding Cytochrome Oxidases and Quinol Monooxygenase Blocks the Aerobic-Anaerobic Shift in Escherichia coli K-12 MG1655 , 2010, Applied and Environmental Microbiology.

[24]  M. Celeste Simon,et al.  The impact of O2 availability on human cancer , 2008, Nature Reviews Cancer.

[25]  Adam D. Richardson,et al.  Central carbon metabolism in the progression of mammary carcinoma , 2007, Breast Cancer Research and Treatment.

[26]  P. Ascierto,et al.  Main roads to melanoma , 2009, Journal of Translational Medicine.

[27]  Gregory Stephanopoulos,et al.  Evaluation of 13C isotopic tracers for metabolic flux analysis in mammalian cells. , 2009, Journal of biotechnology.

[28]  Judy Lucas,et al.  Ammonia Derived from Glutaminolysis Is a Diffusible Regulator of Autophagy , 2010, Science Signaling.

[29]  Tsviya Olender,et al.  GeneCards Version 3: the human gene integrator , 2010, Database J. Biol. Databases Curation.

[30]  W. Wheaton,et al.  Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity , 2010, Proceedings of the National Academy of Sciences.

[31]  L. Chin,et al.  A Role for ATF2 in Regulating MITF and Melanoma Development , 2010, PLoS genetics.

[32]  R. Deberardinis,et al.  Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis , 2007, Proceedings of the National Academy of Sciences.

[33]  D. Tuveson,et al.  Mutant V599EB-Raf regulates growth and vascular development of malignant melanoma tumors. , 2005, Cancer research.

[34]  Christoph Wittmann,et al.  Correcting mass isotopomer distributions for naturally occurring isotopes. , 2002, Biotechnology and bioengineering.

[35]  T. Giordano,et al.  C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells , 2008, Oncogene.

[36]  Elizabeth L. Johnson,et al.  Quiescent Fibroblasts Exhibit High Metabolic Activity , 2010, PLoS biology.

[37]  R. Deberardinis,et al.  Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer , 2010, Oncogene.

[38]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[39]  P. Pilch,et al.  The insulin receptor: structure, function, and signaling. , 1994, The American journal of physiology.

[40]  A. Sherry,et al.  Evidence for reverse flux through pyruvate kinase in skeletal muscle. , 2009, American journal of physiology. Endocrinology and metabolism.

[41]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[42]  N. Price Acylic sugar derivatives for GC/MS analysis of 13C-enrichment during carbohydrate metabolism. , 2004, Analytical chemistry.

[43]  Gregory Stephanopoulos,et al.  Molecular Systems Biology Peer Review Process File Oncogenic K-ras Decouples Glucose and Glutamine Metabolism to Support Cancer Cell Growth Transaction Report , 2022 .